0
0
8/7/23 at 12:01pm
Organization
MarketWatch
Author
Ciara Linnane
33 words
0
Comments
Oppenheimer and Wedbush downgraded Sage’s stock and said they were disappointed by the news
You are the first to view
https://www.marketwatch.com/story/sage-therapeutics-stock-craters-49-after-fda-approves-zuranolone-for-postpartum-depression-but-not-major-depressive-disorder-2648cefa
Create an account
or login to join the discussion